Marshall Wace’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,433
| Closed | -$161K | – | 2590 |
|
|
2024
Q3 | $161K | Buy |
+15,433
| New | +$257K | ﹤0.01% | 2322 |
|
|
2023
Q3 | – | Sell |
-985
| Closed | -$64.8K | – | 2210 |
|
|
2023
Q2 | $64.8K | Buy |
+985
| New | +$72.1K | ﹤0.01% | 2361 |
|
|
2022
Q4 | – | Sell |
-67,040
| Closed | -$8.49M | – | 2946 |
|
|
2022
Q3 | $8.49M | Buy |
67,040
+38,051
| +131% | +$4.3M | 0.02% | 1005 |
|
|
2022
Q2 | $2.4M | Buy |
+28,989
| New | +$2.25M | ﹤0.01% | 1869 |
|
|
2021
Q3 | – | Sell |
-5,971
| Closed | -$2.47M | – | 3039 |
|
|
2021
Q2 | $2.47M | Sell |
5,971
-11,769
| -66% | -$4.66M | 0.01% | 1280 |
|
|
2021
Q1 | $6.93M | Buy |
17,740
+15,254
| +614% | +$7.51M | 0.03% | 644 |
|
|
2020
Q4 | $1.39M | Buy |
+2,486
| New | +$1.58M | 0.01% | 1078 |
|
|
2020
Q1 | – | Sell |
-515
| Closed | -$586K | – | 1639 |
|
|
2019
Q4 | $586K | Sell |
515
-1,251
| -71% | -$1.36M | ﹤0.01% | 1121 |
|
|
2019
Q3 | $2.1M | Buy |
+1,766
| New | +$2.7M | 0.02% | 750 |
|
|
2019
Q2 | – | Sell |
-3,002
| Closed | -$6.12M | – | 1370 |
|
|
2019
Q1 | $6.12M | Buy |
+3,002
| New | +$5.29M | 0.06% | 407 |
|
|
2018
Q1 | – | Sell |
-172
| Closed | -$398K | – | 562 |
|
|
2017
Q4 | $398K | Sell |
172
-99
| -37% | -$201K | 0.02% | 325 |
|
|
2017
Q3 | $482K | Buy |
+271
| New | +$379K | 0.02% | 285 |
|
|
2017
Q2 | – | Sell |
-380
| Closed | -$448K | – | 318 |
|
|
2017
Q1 | $448K | Buy |
+380
| New | +$388K | 0.02% | 252 |
|
|
2016
Q2 | – | Sell |
-800
| Closed | -$441K | – | 992 |
|
|
2016
Q1 | $441K | Sell |
800
-12,203
| -94% | -$7.49M | ﹤0.01% | 870 |
|
|
2015
Q4 | $10.8M | Buy |
13,003
+10,265
| +375% | +$10.3M | 0.1% | 212 |
|
|
2015
Q3 | $3.04M | Buy |
+2,738
| New | +$4.99M | 0.04% | 372 |
|
|
2015
Q2 | – | Sell |
-8,004
| Closed | -$12.5M | – | 905 |
|
|
2015
Q1 | $12.5M | Sell |
8,004
-644
| -7% | -$850K | 0.16% | 161 |
|
|
2014
Q4 | $10.3M | Buy |
8,648
+8,508
| +6,077% | +$5.69M | 0.14% | 189 |
|
|
2014
Q3 | $65K | Sell |
140
-2,019
| -94% | -$932K | ﹤0.01% | 840 |
|
|
2014
Q2 | $1.08M | Buy |
+2,159
| New | +$692K | 0.02% | 491 |
|
Other funds holding BLUE
APM
LPC
PHS
Marshall Wace's BLUE Position: Q4 2024 in Review
Marshall Wace sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 15,433 shares — an estimated $161K sold.
Marshall Wace first reported a position in BLUE in Q2 2014 and held it in 20 quarters. The position peaked at $12.5M in Q1 2015. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.
- Marshall Wace reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
- Marshall Wace sold 15,433 bluebird bio shares in Q4 2024, an estimated $161K.
- Marshall Wace first reported a position in bluebird bio in Q2 2014 and held it in 20 quarters.
- Marshall Wace's bluebird bio position peaked at $12.5M in Q1 2015.
- 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.
Based on Marshall Wace's 13F filing for Q4 2024, filed 13 Feb 2025.